CK 1649C
Alternative Names: CK 1649Latest Information Update: 12 Dec 1994
At a glance
- Originator Bayer HealthCare Pharmaceuticals
- Class Class III antiarrhythmics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias